formoterol fumarate has been researched along with arformoterol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alikhani, V; Beer, D; Bentley, D; Bruce, I; Cuenoud, BM; Fairhurst, RA; Gedeck, P; Haberthuer, S; Hayden, C; Janus, D; Jordan, L; Lewis, C; Smithies, K; Wissler, E | 1 |
| Beattie, D; Bradley, M; Brearley, A; Charlton, SJ; Cuenoud, BM; Fairhurst, RA; Gedeck, P; Gosling, M; Janus, D; Jones, D; Lewis, C; McCarthy, C; Oakman, H; Stringer, R; Taylor, RJ; Tuffnell, A | 1 |
2 other study(ies) available for formoterol fumarate and arformoterol
| Article | Year |
|---|---|
Long-chain formoterol analogues: an investigation into the effect of increasing amino-substituent chain length on the beta2-adrenoceptor activity.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Ethanolamines; Formoterol Fumarate; Guinea Pigs; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Salmeterol Xinafoate; Stereoisomerism; Structure-Activity Relationship; Time Factors | 2004 |
A physical properties based approach for the exploration of a 4-hydroxybenzothiazolone series of beta2-adrenoceptor agonists as inhaled long-acting bronchodilators.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Antagonists; Bronchodilator Agents; Thiazoles | 2010 |